- Q3 2026 GAAP net loss widened to $73.3M ($1.33/share) compared to $43M ($0.92/share) in Q3 2025.
- Non-GAAP adjusted net loss was $66.8M; operating expenses increased significantly to $77.3M.
- REVTORPYK launched commercially on Sept 30, with 91% coverage across US commercial and Medicare lives and $178.2M in cash reserves.
Why is $CELC moving today? · SEC 8-K archive
$CELC SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $CELC: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $CELC filing catalyst
Why did $CELC trigger an AI stock catalyst alert?
$CELC triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -2.5/10). Headline: Celcuity Reports Q3 Net Loss of $73.3M Amid REVTORPYK Commercial Launch. Key points: - Q3 2026 GAAP net loss widened to $73.3M ($1.33/share) compared to $43M ($0.92/share) in Q3 2025. - Non-GAAP adjusted net loss was $66.8M; operating expenses increased significantly to $77.3M. - REVTORPYK launched commercially on Sept 30, with 91% coverage across US commercial and Medicare lives and $178.2M in cash reserves.
How did $CELC stock react after the SEC filing?
After the SEC 8-K for $CELC, observed market reaction: T0 price $64.04. Past moves do not guarantee future results.
Where can I get real-time $CELC SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $CELC via Telegram and the VIP Web Terminal from €10/month.